GHRP-2 / Tesamorelin / MGF / Ipamorelin Blend (5MG/5MG/500MCG/2.5MG)
$ 67.50
Description This experimental blend combines four highly characterized synthetic peptides to facilitate advanced research into the hypothalamic-pituitary-somatotropic axis and downstream cellular hypertrophy: Tesamorelin: A stabilized GHRH analogue that binds to anterior pituitary receptors to stimulate gene transcription and release of endogenous growth hormone (GH). GHRP-2 (Pralmorelin) & Ipamorelin: Synthetic growth hormone secretagogues (GHS) that act as agonists at the ghrelin/growth hormone secretagogue receptor (GHSR-1a). While GHRP-2 is a potent stimulator, Ipamorelin provides highly selective GH release without significantly elevating adrenocorticotropic hormone (ACTH) or prolactin. 1 MGF (Mechano Growth Factor): An alternative splice variant of IGF-1 (IGF-1Ec) natively expressed in response to mechanical overload. It is utilized to study satellite cell activation and localized tissue repair independently of systemic IGF-1 pathways. In experimental models, the concurrent administration of a GHRH analogue (Tesamorelin) and GHSR-1a agonists (GHRP-2, Ipamorelin) produces a highly synergistic, rather than additive, amplification of pulsatile GH secretion. The inclusion of MGF allows researchers to simultaneously observe localized autocrine/paracrine cellular repair mechanisms in muscle and connective tissue assays. Biochemical Characteristics Chemically, this blend provides a multi-receptor targeting approach for in vitro and in vivo metabolic assays. Sequence/Structure: A proprietary blend of four distinct peptide structures (GHRH analogue, two hexapeptide/pentapeptide GHS analogues, and an IGF-1 splice variant). Receptor Affinity: Simultaneously targets the GHRH receptor (GHRHR), the Ghrelin receptor (GHSR-1a), and mechanosensitive receptors associated with satellite cell activation. Stability: Supplied as a co-lyophilized salt to ensure long-term stability and prevent hydrolytic or proteolytic degradation of the individual peptide chains during storage. Specificity: Designed to competitively stimulate the somatotropic axis while minimizing off-target neuroendocrine interference (e.g., cortisol spiking). Chemical Properties Property Specification Molecule Name GHRP-2 / Tesamorelin / MGF / Ipamorelin Blend Component Ratios GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg) Form Lyophilized Powder Purity ≥99% (Verified via HPLC for all components) Solubility Soluble in water and organic solvents (refer to SDS) Documentation COA available per lot; SDS available (Note: Exact Molecular Weights and individual component Formulas should be verified per lot COA/SDS, as this is a blended product.)
